-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Intraday Session
Share
Listen to the news

Gainers

  • Palisade Bio (NASDAQ:PALI) stock rose 86.0% to $1.6 during Wednesday's regular session. The company's market cap stands at $8.0 million.
  • Larimar Therapeutics (NASDAQ:LRMR) shares increased by 30.8% to $4.22. The market value of their outstanding shares is at $276.4 million.
  • Aspire Biopharma Hldgs (NASDAQ:ASBP) stock rose 25.48% to $0.26. The market value of their outstanding shares is at $10.2 million.
  • Jyong Biotech (NASDAQ:MENS) shares moved upwards by 24.42% to $49.0. The company's market cap stands at $2.9 billion.
  • Healthcare Triangle (NASDAQ:HCTI) shares moved upwards by 24.14% to $3.27. The market value of their outstanding shares is at $15.3 million.
  • Indaptus Therapeutics (NASDAQ:INDP) shares rose 18.64% to $3.4. The company's market cap stands at $3.1 million.

Losers

  • Fortress Biotech (NASDAQ:FBIO) shares decreased by 29.5% to $2.6 during Wednesday's regular session. The company's market cap stands at $109.9 million.
  • Fortress Biotech (NASDAQ:FBIOP) stock fell 17.4% to $7.6. The company's market cap stands at $31.5 million.
  • Akanda (NASDAQ:AKAN) stock fell 16.88% to $3.62. The company's market cap stands at $3.1 million.
  • MSP Recovery (NASDAQ:MSPR) shares fell 14.61% to $0.96. The market value of their outstanding shares is at $1.1 million.
  • Vor Biopharma (NASDAQ:VOR) shares fell 12.96% to $42.41. The market value of their outstanding shares is at $333.9 million.
  • Definitive Healthcare (NASDAQ:DH) stock declined by 10.6% to $3.63. The company's market cap stands at $422.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending